The Peripheral Nervous System Complications of HTLV-1 Myelopathy (HAM/TSP) Syndromes

ABSTRACT

Human T-cell lymphotropic virus type I (HTLV-1) is a human retrovirus and the etiologic agent for a progressive neurological disease called HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). With its primary site of involvement occurring at the thoracic spinal cord level, HAM/TSP is characterized by muscle weakness, hyperreflexia, lower extremity spasticity, and urinary disturbance. However, HAM/TSP has also been associated with other autoimmune disorders as well as widespread dysfunction within the nervous system that results in less frequent symptoms of cerebral, cerebellar, and cranial nerve involvement. Although masked by the more prominent myelopathy, involvement of the peripheral nervous system also occurs. Syndromes of anterior horn cell, peripheral nerve, and muscle dysfunction have been reported.

KEYWORDS

HTLV-I infection - HAM/TSP - neuromuscular - neuropathy - myopathy

REFERENCES

• 1 Montgomery R D, Cruickshank E K, Robertson W B, McMenemey W H. Clinical and pathological observations on Jamaican neuropathy.  Brain. 1964;  87 425-462
• 2 Rodgers-Johnson P, Morgan O S, Mora C et al.. The role of HTLV-I in tropical spastic paraparesis in Jamaica.  Ann Neurol. 1988;  23(suppl) S121-S126
• 3 Gessain A, Barin F, Vernant J C et al.. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis.  Lancet. 1985;  2 407-410
• 4 Osame M, Usuku K, Izumo S et al.. HTLV-1 associated myelopathy, a new clinical entity [letter].  Lancet. 1986;  1 1031-1032
• 5 Sugimura K, Takahashi A, Watanabe M, Mano K, Watanabe H. Demyelinating changes in sural nerve biopsy of patients with HTLV-I-associated myelopathy.  Neurology. 1990;  40 1263-1266
• 6 Román G C. The neuroepidemiology of tropical spastic paresis.  Ann Neurol. 1988;  23(suppl) S113-S120
• 7 Uchiyama T. Human T cell leukemia virus type I (HTLV-I).  Annu Rev Immunol. 1997;  15 15-37
• 8 Nakagawa M, Izumo S, Ijichi S et al.. HTLV-I-associated myelopathy: analysis of 213 patients based on clinical features and laboratory findings.  J Neurovirol. 1995;  1 50-61
• 9 Di Rocco A. HIV-associated myelopathy.  Current Treatment Options in Infectious Diseases. 2003;  5 457-465
• 10 Zaninovic V. Similarities between tropical spastic paraparesis (TSP) and neurolathyrism.  Lathyrus Lathyrism Newsletter. 2001;  2 11-14
• 11 Araújo A, Hall W W. Human T-lymphotropic virus type II and neurological disease.  Ann Neurol. 2004;  56 10-19
• 12 Edlich R F, Arnette J A, Williams F M. Global epidemic of human T-cell lymphotropic virus type-1 (HTLV-1).  J Emerg Med. 2000;  18 109-119
• 13 Simms I, Tosswill J HC, Noone A, Morgan D. Surveillance of HTLV infection in England and Wales: 1986-1992.  Commun Dis Rep CDR Rev. 1994;  4 R65-R69
• 14 Vrielink H, Reesink H W. HTLVI/II prevalence in different geographic locations.  Transfus Med Rev. 2004;  18 46-57
• 15 Vernant J C, Maurs L, Gessain A et al.. Endemic tropical spastic paraparesis associated with human T-lymphotropic virus type 1: a clinical and seroepidemiological study of 25 cases.  Ann Neurol. 1987;  21 123-130
• 16 Araújo A de Q, Afonso C R, Schor D, Leite A C, de Andrada-Serpa M J. Clinical and demographic features of HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Rio de Janeiro, Brazil.  Acta Neurol Scand. 1993;  88 59-62
• 17 Bhigjee A I, Kelbe C, Haribhal H C et al.. Myelopathy associated with human T cell lymphotropic virus type I (HTLV-I) in Natal, South Africa.  Brain. 1990;  113 1307-1320
• 18 Tylleskär T, Banea M, Bikangi N, Cooke R D, Poulter N H, Rosling H. Cassava cyanogens and konzo, an upper motoneuron disease found in Africa.  Lancet. 1992;  339 208-211
• 19 Ludolph A C, Spencer P S. Toxic models of upper motor neuron disease.  J Neurol Sci. 1996;  139 53-59
• 20 Tylleskar T, Banea M, Bikangi N, Cooke R D, Poulter N H, Rosling H. Cassava cyanogens and konzo, an upper motoneuron disease found in Africa.  Lancet. 1992;  339 208-211
• 21 Getahun H, Mekonnen A, TekleHaimanot R, Lambein F. Epidemic of neurolathyrism in Ethiopia.  Lancet. 1999;  354 306-307
• 22 Getahun H, Lambein F, Vanhoorne M, Van der Stuyft P. Pattern and associated factors of the neurolathyrism epidemic in Ethiopia.  Trop Med Int Health. 2002;  7 118-124
• 23 Shasi Vardhan K, Pratap Rudra M P, Rao S L. Inhibition of tyrosine aminotransferase by β-N-oxalyl-L-a‚β-diaminopropionic acid, the Lathyrus sativus neurotoxin.  J Neurochem. 1997;  68 2477-2484
• 24 Oluwole O SA, Onabolu A O, Link H, Rosling H. Persistence of tropical ataxic neuropathy in a Nigerian community.  J Neurol Neurosurg Psychiatry. 2000;  69 96-101
• 25 Oluwole O SA, Onabolu A O, Cotgreave I A, Rosling H, Persson A, Link H. Incidence of endemic ataxic polyneuropathy and its relation to exposure to cyanide in a Nigerian community.  J Neurol Neurosurg Psychiatry. 2003;  74 1417-1422
• 26 Oluwole O SA, Onabolu A O, Link H, Rosling H. Persistence of tropical ataxic neuropathy in a Nigerian community.  J Neurol Neurosurg Psychiatry. 2000;  69 96-101
• 27 Kaplan J E, Osama M, Kubota H et al.. The risk of development of HTLV-1-associated myelopathy/tropical spastic paraparesis among persons infected with HTLV-I.  J Acquir Immune Defic Syndr. 1990;  3 1096-1101
• 28 Nagai M, Usuku K, Matsumoto W et al.. Analysis of HTLV-1 proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-1 carriers: high proviral load strongly predisposes to HAM/TSP.  J Neurovirol. 1998;  4 586-593
• 29 Gout O, Baulac M, Gessain A et al.. Rapid development of myelopathy after HTLV-I infection acquired by transfusion during cardiac transplantation.  N Engl J Med. 1990;  322 383-388
• 30 Toro C, Rodé B, Poveda E, Soriano V. Rapid development of subacute myelopathy in three organ transplant recipients after transplantation of human T-cell lymphotropic virus type I from a single donor.  Transplantation. 2003;  75 102-104
• 31 Jacobson S. Immunopathogenesis of human T cell lymphotropic virus type I-associated neurologic disease.  J Infect Dis. 2002;  186(suppl 2) 187-192
• 32 Imirizaldu J J, Esteban J C, Axpe I R et al.. Post-transplantation HTLV-1 myelopathy in three recipients from a single donor.  J Neurol Neurosurg Psychiatry. 2003;  74 1080-1084
• 33 Izumo S, Goto I, Itoyama Y et al.. Interferon-alpha is effective in HTLV-I associated myelopathy: a multicenter, double-blind, controlled trial.  Neurology. 1996;  46 1016-1021
• 34 Alamy A H, Menezes F B, Leite A C, Nascimento O M, Araujo A Q. Dysautonomia in human T-cell lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis.  Ann Neurol. 2001;  50 681-685
• 35 Silva M TT, Mattos P, Alfano A, Araújo A Q-C. Neuropsychological assessment in HTLV-1 infection: a comparative study among TSP/HAM, asymptomatic carriers, and healthy controls.  J Neurol Neurosurg Psychiatry. 2003;  74 1085-1089
• 36 Nakagawa M, Nakahara K, Maruyama Y et al.. Therapeutic trials in 200 patients with HTLV-I-associated myelopathy/tropical spastic paraparesis.  J Neurovirol. 1996;  2 345-355
• 37 Saito M, Nakagawa M, Kaseda S et al.. Decreased human T lymphotropic virus type I (HTLV-I) provirus load and alteration in T cell phenotype after interferon-α therapy for HTLV-I-associated myelopathy/tropical spastic paraparesis.  J Infect Dis. 2004;  189 29-40
• 38 Silva M T, Araújo A. Spinal cord swelling in human T-lymphotropic virus 1-associated myelopathy/tropical spastic paraparesis.  Arch Neurol. 2004;  61 1134-1135
• 39 Iwasaki Y. Human T cell leukemia virus type I infection and chronic myelopathy.  Brain Pathol. 1993;  3 1-10
• 40 Abe M, Umehara F, Kubota R, Moritoyo T, Izumo S, Osame M. Activation of macrophages/microglia with the calcium-binding proteins MRP14 and MRP8 is related to the lesional activities in the spinal cord of HTLV-I associated myelopathy.  J Neurol. 1999;  246 358-364
• 41 Retroviruses. In: Murray PR, Rosenthal KS, Kobayashi GS, Pfaller MA Medical Microbiology. 4th ed. St. Louis; Mosby 2002: 574-590
• 42 Derse D, Heidecker G. Virology: forced entry-or does HTLV-1 have the key? [comments].  Science. 2003;  299 1670-1671
• 43 Hisada M, Stuver S O, Okayama A et al.. Persistent paradox of natural history of human T lymphotropic virus type I: parallel analyses of Japanese and Jamaican carriers.  J Infect Dis. 2004;  190 1605-1609
• 44 Hisada M, Maloney E M, Sawada T et al.. Virus markers associated with vertical transmission of human T lymphotropic virus type 1 in Jamaica.  Clin Infect Dis. 2002;  34 1551-1557
• 45 Bangham C RM. Human T-lymphotropic virus type 1 (HTLV-1): persistence and immune control.  Int J Hematol. 2003;  78 297-303
• 46 Barmak K, Harhaj E, Grant C, Alefantis T, Wigdahl B. Human T cell leukemia virus type I induced disease: pathways to cancer and neurodegeneration.  Virology. 2003;  308 1-12
• 47 Brew B J. The peripheral nerve complications of human immunodeficiency virus (HIV) infection.  Muscle Nerve. 2003;  28 542-552
• 48 Kiwaki T, Umehara F, Arimura Y et al.. The clinical and pathological features of peripheral neuropathy accompanied with HTLV-I associated myelopathy.  J Neurol Sci. 2003;  206 17-21
• 49 Arimura K, Arimura Y, Moritoyo H et al.. How helpful is thoracic paraspinal EMG in HAM/TSP?.  Muscle Nerve. 1995;  18 248-250
• 50 Corbin D O, Mora C A, Garriques S, Rodgers-Johnson P, Gibbs C J. Anterior horn cell degeneration in polymyositis associated with human T lymphotropic virus type-1 in patients from Barbados.  Am J Trop Med Hyg. 1996;  54 625-628
• 51 Ross M A, Miller R G, Berchert L et al.. Toward earlier diagnosis of amyotrophic lateral sclerosis: revised criteria.  Neurology. 1998;  50 768-772
• 52 Matsuzaki T, Nakagawa M, Nagai M et al.. HTLV-I-associated myelopathy (HAM)/tropical spastic paraparesis (TSP) with amyotrophic lateral sclerosis-like manifestations.  J Neurovirol. 2000;  6 544-548
• 53 Kuroda Y, Sugihara H. Autopsy report of HTLV-I-associated myelopathy presenting with ALS-like manifestations.  J Neurol Sci. 1991;  106 199-205
• 54 Vernant J C, Buisson G, Bellance R, Francois M A, Madkaud O, Zavaro O. Pseudo-amyotrophic lateral sclerosis, peripheral neuropathy and chronic polyradiculoneuritis in patients with HTLV-I-associated paraplegias. In: Roman G, Vernant JC, Osame M HTLV-1 and the Nervous System. New York; Alan R. Liss, Inc. 1989: 361-365
• 55 Evans B K, Gore I, Harrell L E, Arnold T, Oh S J. HTLV-I-associated myelopathy and polymyositis in a US native.  Neurology. 1989;  39 1572-1575
• 56 Arimura K, Nakashima H, Matsumoto W et al.. HTLV-I-associated myelopathy (HAM) presenting with ALS-like features. In: Roman G, Vernant JC, Osame M HTLV-1 and the Nervous System. New York; Alan R. Liss, Inc. 1989: 367-370
• 57 Cruickshank J K, Rudge P, Dalgleish A G et al.. Tropical spastic paraparesis and human T cell lymphotropic virus type I in the United Kingdom.  Brain. 1989;  112 1057-1090
• 58 Leite A CC, Silva M TT, Alamy A H et al.. Peripheral neuropathy in HTLV-1 infected individuals without tropical spastic paraparesis/HTLV-1-associated myelopathy.  J Neurol. 2004;  251 877-881
• 59 Nascimento O JM, Araújo A Q, Freitas M RG, Escada T M, Andrad-Serpa M J. Peripheral nerve involvement in HTLV-I associated myelopathy [abstract].  J Acquir Immune Defic Syndr. 1995;  10 230
• 60 Ludolph A C, Hugon J, Román G C, Spencer P S, Schoenberg B S. A clinical neurophysiologic study of tropic spastic paraparesis.  Muscle Nerve. 1988;  11 392-397
• 61 Barkhaus P E, Morgan O. Jamaican neuropathy: an electrophysiological study.  Muscle Nerve. 1988;  11 380-385
• 62 Bhigjee A I, Bill P LA, Wiley C A et al.. Peripheral nerve lesions in HTLV-I associated myelopathy (HAM/TSP).  Muscle Nerve. 1993;  16 21-26
• 63 Douen A G, Pringle C E, Guberman A. Human T-cell lymphotropic virus type-1 myositis, peripheral neuropathy, and cerebral white matter lesions in the absence of spastic paraparesis.  Arch Neurol. 1997;  54 896-900
• 64 Said G, Goulon-Goeau C, Lacroix C, Fève A, Descamps H, Fouchard M. Inflammatory lesions of peripheral nerve in a patient with human T-lymphotropic virus type I-associated myelopathy.  Ann Neurol. 1988;  24 275-277
• 65 Nakazato O, Mori T, Okajima T. Sural nerve pathology in HTLV-I-associated myelopathy. In: Roman G, Vernant JC, Osame M HTLV-1 and the Nervous System. New York; Alan R. Liss, Inc. 1989: 269-274
• 66 Nakazato O, Mori T, Okajima T. Sural nerve pathology in HTLV-I associated myelopathy.  Neurol Neurobiol. 1989;  51 269-274
• 67 Littleton E T, Man W D, Holton J L et al.. Human T cell leukemia virus type 1 associated neuromuscular disease causing respiratory failure.  J Neurol Neurosurg Psychiatry. 2002;  72 650-652
• 68 Cupler E J, Leon-Monzon M, Miller J et al.. Inclusion body myositis in HIV and HTLV-1 infected patients.  Brain. 1996;  119 1887-1893
• 69 Ozden S, Gessain A, Gout O et al.. Sporadic inclusion body myositis in a patient with human T-cell leukemia virus type-1 associated myelopathy.  Clin Infect Dis. 2001;  32 510-514
• 70 Leon-Monzon M, Illa I, Dalakas M C. Polymyositis in patients infected with human T-cell leukemia virus type 1: the role of the virus in the cause of the disease.  Ann Neurol. 1994;  36 643-649
• 71 Morgan O S, Rodgers-Johnson P, Mora C, Char G. HTLV-1 and polymyositis in Jamaica.  Lancet. 1989;  2 1184-1187
• 72 Higuchi I, Nerenberg M, Yoshimine K et al.. Failure to detect HTLV-1 by in situ hybridization in the biopsied muscles of viral carriers with polymyositis.  Muscle Nerve. 1992;  15 43-44
• 73 Nishikai M, Sato A. Human T lymphocyte virus type I and polymyositis and dermatomyositis in Japan [letter].  Arthritis Rheum. 1991;  34 791-792
• 74 Inose M, Higuchi I, Yoshimine K et al.. Pathological changes in skeletal muscle in HTLV-1 seropositive myelopathy.  J Neurol Sci. 1992;  110 73-78
• 75 Smadja D, Bellance R, Cabre P h et al.. Clinical characteristics of HTLV-1 associated dermato-polymyositis: seven cases from Martinique.  Acta Neurol Scand. 1995;  92 206-212
• 76 Sowa J M. Human T lymphotropic virus I, myelopathy, polymyositis, and synovitis: an expanding rheumatic spectrum.  J Rheumatol. 1992;  19 316-318
• 77 Gabbai A A, Wiley C A, Oliveira A SB et al.. Skeletal muscle involvement in tropical spastic paraparesis/HTLV-1-associated myelopathy.  Muscle Nerve. 1994;  17 923-930
• 78 Tarras S, Sheremata W A, Snodgrass S, Ayyar D R. Polymyositis and chronic myelopathy with presence of serum and cerebrospinal fluid antibody to HTLV-I. In: Roman G, Vernant JC, Osame M HTLV-1 and the Nervous System. New York; Alan R. Liss, Inc. 1989: 435-441